Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seventeen ratings firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating, twelve have issued a buy rating […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.